Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
Soin et al., The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(21)00081-3
https://c19early.org/soin.html